Moreover, one of the meta-analyses showed that a higher level of fetuin-A was more pronounced in the non-alcoholic steatohepatitis (NASH) group than in the NAFLD group [39]. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.